QA: Carisma Therapeutics Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2018_Carisma_Therapeutics_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc

  xvar xval
0 AssetsCurrent 14,981,000
1 IntangibleAssetsNetIncludingGoodwill 59,464,000
2 PropertyPlantAndEquipmentNet 522,000
3 remainder_Assets 130,000
4 LiabilitiesCurrent 4,720,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,914,638
9 ResearchAndDevelopmentExpense 12,501,789
10 remainder_Expenses -1,095,000
11 remainder_Revenues 131,088
12 remainder_NetIncome 22,706,388
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 75,097,000
1 Liabilities 4,720,000
2 Expenses 20,321,427
3 Revenues 131,088
4 StockholdersEquity 70,377,000
5 NetIncome 2,516,049
6 ComprehensiveNetIncome 2,516,049
7 BaseVar 61,487,952
8 EconomicCapitalRatiobeforeLimitedLiability 3.91
9 EconomicCapitalRatio 4.32

Edgar->Model Mapping

Feature Distribution

Change over Time